Thyroid Updates by Professor Steven Boyages

Search This Blog

Exelixis Gets FDA Orphan Drug Status For Cancer Drug XL184 - Update

on January 23, 2011

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

Exelixis Gets FDA Orphan Drug Status For Cancer Drug XL184 - Update
New cancer drug for patients with advanced forms of thyroid cancer.

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

Comments

How does COVID-19 impact the thyroid?

https://blogs.bcm.edu/2021/01/25/how-does-covid-19-impact-the-thyroid/ Main takeaways are: 1) pre-existing thyroid dysfunction does not lead to an increased COVID-19 infection rate or a worse prognosis during a COVID-19 infection, 2) COVID-19 can cause acute hypothyroidism via the non-thyroidal illness syndrome 3) COVID-19 can cause subacute hyperthyroidism, and 4) COVID-19 can cause overt thyrotoxicosis via direct inflammation of the thyroid. Long-term most acute thyroid dysfunction resolves once the patient has cleared the COVID-19 infection.

Tepezza for thyroid eye disease

New Dietary guidelines for Americans 2015-2020

https://health.gov/sites/default/files/2019-09/2015-2020_Dietary_Guidelines.pdf

Powered by Blogger

This information is intended for a general audience and is not a substitute for a doctor's advice.

Exelixis Gets FDA Orphan Drug Status For Cancer Drug XL184 - Update

Comments

Post a Comment